{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T13:44:17Z","timestamp":1748007857918,"version":"3.37.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T00:00:00Z","timestamp":1730505600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010398","name":"Metro South Health","doi-asserted-by":"publisher","award":["252-19\/20","RSS_2021_027"],"award-info":[{"award-number":["252-19\/20","RSS_2021_027"]}],"id":[{"id":"10.13039\/100010398","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and Objective<\/jats:title>\n                <jats:p>Accurate and robust adverse event (AE) data collection is crucial in cancer clinical trials to ensure participant safety. Frameworks have been developed to facilitate the collection of AE data and now the traditional workflows are facing renewal to include patient-reported data, improving completeness of AE data. We explored one of these workflows in a cancer clinical trial unit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study was a single-site study conducted at a tertiary hospital located in Australia. Patients consenting to a clinical trial were eligible for inclusion in this study. Participants used an electronic platform\u2014My Health My Way (MHMW)\u2014to report their symptomatic data weekly for 24 weeks. A symptom list was included within the platform, along with a free text field. Data reported via the platform was compared with data recorded in the patient\u2019s medical chart. Time taken to compile data from each source was recorded, along with missing data points. Agreement between patient-reported data and data recorded in the medical notes was assessed using Kappa and Gwet\u2019s AC<jats:sub>1<\/jats:sub>; time taken to compile data and missing data points were assessed using a Wilcoxon signed rank test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Low agreement was found between patient- and clinician-reported data (\u2212\u00a00.482 and \u2212\u00a00.159 by Kappa and Gwet\u2019s AC<jats:sub>1<\/jats:sub> respectively). Only 127 (30%) of the total 428 AEs were reported by both MHMW and medical notes. Patients reported higher rates of symptoms from the symptom list, while clinicians reported higher rates of symptoms outside of the symptom list. Time taken to compile the data from MHMW was significantly less than that taken to review medical notes (2.19\u00a0min versus 5.73\u00a0min respectively; <jats:italic>P<\/jats:italic> &lt;\u00a0 0.001). There were significantly less missing data points from the MHMW data compared with the medical notes (1.4 versus 7.8; <jats:italic>P<\/jats:italic>\u00a0&lt;\u00a00.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This study confirms previous reports that patient- and clinician-reported adverse event data show low agreement. This study also shows that clinical trial sites could significantly reduce the work performed by research staff in the collection of adverse event data by implementing an electronic, patient-reported platform.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40801-024-00461-y","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T10:06:54Z","timestamp":1730542014000},"page":"725-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Pilot Study on the Collection of Adverse Event Data from the Patient Using an Electronic Platform in a Cancer Clinical Trial Unit"],"prefix":"10.1007","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9318-9778","authenticated-orcid":false,"given":"Minna","family":"Grahvendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7537-2402","authenticated-orcid":false,"given":"Bena","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9474-9121","authenticated-orcid":false,"given":"Laurelie R.","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,2]]},"reference":[{"key":"461_CR1","unstructured":"International Council for Harmonisation. Guideline for Good Clinical Practice E6(R2) [Internet]. 2016 [cited 2022 Feb 5]. https:\/\/database.ich.org\/sites\/default\/files\/E6_R2_Addendum.pdf. Accessed 5 Feb 2022."},{"key":"461_CR2","doi-asserted-by":"publisher","unstructured":"Liu MB, Davis K. Adverse events and unanticipated problems involving risks to subjects or others. In: A clinical trials manual from the Duke Clinical Research Institute [Internet], 2nd ed. Chichester: Wiley-Blackwell; 2010. pp. 123\u201339. https:\/\/doi.org\/10.1002\/9781444315219.ch6.","DOI":"10.1002\/9781444315219.ch6"},{"key":"461_CR3","unstructured":"National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) [Internet]. 2021 [cited 2024 Jan 6]. https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm."},{"issue":"17","key":"461_CR4","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","volume":"22","author":"EK Fromme","year":"2004","unstructured":"Fromme EK, Eilers KM, Mori M, Hsieh YC, Beer TM. How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol. 2004;22(17):3485\u201390.","journal-title":"J Clin Oncol"},{"issue":"5","key":"461_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.2217\/cer-2018-0092","volume":"8","author":"F Sparano","year":"2019","unstructured":"Sparano F, Aaronson NK, Cottone F, Piciocchi A, La Sala E, Anota A, et al. Clinician-reported symptomatic adverse events in cancer trials: are they concordant with patient-reported outcomes? J Comp Eff Res [Internet]. 2019;8(5):279\u201388. https:\/\/doi.org\/10.2217\/cer-2018-0092.","journal-title":"J Comp Eff Res [Internet]."},{"issue":"11","key":"461_CR6","doi-asserted-by":"publisher","first-page":"3009","DOI":"10.1007\/s11136-020-02558-7","volume":"29","author":"L Liu","year":"2020","unstructured":"Liu L, Suo T, Shen Y, Geng C, Song Z, Liu F, et al. Clinicians versus patients subjective adverse events assessment: based on patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Qual Life Res [Internet]. 2020;29(11):3009\u201315. https:\/\/doi.org\/10.1007\/s11136-020-02558-7.","journal-title":"Qual Life Res [Internet]."},{"issue":"7","key":"461_CR7","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s11136-011-0031-4","volume":"21","author":"TM Atkinson","year":"2012","unstructured":"Atkinson TM, Li Y, Coffey CW, Sit L, Shaw M, Lavene D, et al. Reliability of adverse symptom event reporting by clinicians. Qual Life Res. 2012;21(7):1159\u201364.","journal-title":"Qual Life Res"},{"key":"461_CR8","doi-asserted-by":"publisher","unstructured":"Fayers PM, Machin D. Biased reporting and response shift. In: Fayers PM, Machin D, editors. Quality of Life: The assessment, analysis and reporting of patient-reported outcomes [Internet], 3rd Edn. Chichester: Wiley Blackwell; 2016. pp. 511\u201326. https:\/\/doi.org\/10.1002\/9781118758991.ch19.","DOI":"10.1002\/9781118758991.ch19"},{"issue":"2","key":"461_CR9","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1586\/14737167.4.2.159","volume":"4","author":"JK Schmier","year":"2004","unstructured":"Schmier JK, Halpern MT. Patient recall and recall bias of health state and health status. Expert Rev Pharmacoecon Outcomes Res [Internet]. 2004;4(2):159\u201363. https:\/\/doi.org\/10.1586\/14737167.4.2.159.","journal-title":"Expert Rev Pharmacoecon Outcomes Res [Internet]."},{"issue":"15","key":"461_CR10","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2005.04.275","volume":"23","author":"E Basch","year":"2005","unstructured":"Basch E, Artz D, Dulko D, Scher K, Sabbatini P, Hensley M, et al. Patient online self-reporting of toxicity symptoms during chemotherapy. J Clin Oncol [Internet]. 2005;23(15):3552\u201361. https:\/\/doi.org\/10.1200\/JCO.2005.04.275.","journal-title":"J Clin Oncol [Internet]."},{"issue":"32","key":"461_CR11","doi-asserted-by":"publisher","first-page":"5121","DOI":"10.1200\/JCO.2007.12.4784","volume":"25","author":"A Trotti","year":"2007","unstructured":"Trotti A, Colevas AD, Setser A, Basch E. Patient-reported outcomes and the evolution of adverse event reporting in oncology. J Clin Oncol [Internet]. 2007;25(32):5121\u20137. https:\/\/doi.org\/10.1200\/JCO.2007.12.4784.","journal-title":"J Clin Oncol [Internet]."},{"issue":"5","key":"461_CR12","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/nrclinonc.2015.222","volume":"13","author":"M Di Maio","year":"2016","unstructured":"Di Maio M, Basch E, Bryce J, Perrone F. Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. Nat Rev Clin Oncol [Internet]. 2016;13(5):319\u201325.","journal-title":"Nat Rev Clin Oncol [Internet]."},{"issue":"2","key":"461_CR13","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/1740774520972125","volume":"18","author":"F Kennedy","year":"2021","unstructured":"Kennedy F, Shearsmith L, Ayres M, Lindner OC, Marston L, Pass A, et al. Online monitoring of patient self-reported adverse events in early phase clinical trials: views from patients, clinicians, and trial staff. Clin Trials [Internet]. 2021;18(2):168\u201379. https:\/\/doi.org\/10.1177\/1740774520972125.","journal-title":"Clin Trials [Internet]."},{"issue":"31","key":"461_CR14","doi-asserted-by":"publisher","first-page":"3120","DOI":"10.1200\/JCO.2018.78.8620","volume":"36","author":"E Basch","year":"2018","unstructured":"Basch E, Dueck AC, Rogak LJ, Mitchell SA, Minasian LM, Denicoff AM, et al. Feasibility of implementing the patient-reported outcomes version of the common terminology criteria for adverse events in a multicenter Trial: NCCTG N1048. J Clin Oncol [Internet]. 2018;36(31):3120\u20135. https:\/\/doi.org\/10.1200\/JCO.2018.78.8620.","journal-title":"J Clin Oncol [Internet]."},{"issue":"8","key":"461_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/jamaoncol.2016.6749","volume":"3","author":"E Basch","year":"2017","unstructured":"Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Feasibility assessment of patient reporting of symptomatic adverse events in multicenter cancer clinical trials. JAMA Oncol [Internet]. 2017;3(8):1043. https:\/\/doi.org\/10.1001\/jamaoncol.2016.6749.","journal-title":"JAMA Oncol [Internet]."},{"issue":"2","key":"461_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ijrobp.2017.02.002","volume":"98","author":"E Basch","year":"2017","unstructured":"Basch E, Pugh SL, Dueck AC, Mitchell SA, Berk L, Fogh S, et al. Feasibility of patient reporting of symptomatic adverse events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group multicenter clinical trial. Int J Radiat Oncol Biol Phys [Internet]. 2017;98(2):409\u201318.","journal-title":"Int J Radiat Oncol Biol Phys [Internet]."},{"key":"461_CR17","unstructured":"National Cancer Institute. Patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) [Internet]. 2022. https:\/\/healthcaredelivery.cancer.gov\/pro-ctcae\/."},{"key":"461_CR18","doi-asserted-by":"publisher","unstructured":"Basch E, Reeve BB, Mitchell SA, Clauser SB, Minasian LM, Dueck AC, et al. Development of the National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). JNCI J Natl Cancer Inst [Internet]. 2014;106(9):dju244. https:\/\/doi.org\/10.1093\/jnci\/dju244.","DOI":"10.1093\/jnci\/dju244"},{"issue":"1","key":"461_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1177\/1740774520975120","volume":"18","author":"E Basch","year":"2021","unstructured":"Basch E, Becker C, Rogak LJ, Schrag D, Reeve BB, Spears P, et al. Composite grading algorithm for the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Clin Trials. 2021;18(1):104\u201314.","journal-title":"Clin Trials"},{"issue":"2","key":"461_CR20","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1200\/JCO.2002.20.2.545","volume":"20","author":"K Roche","year":"2002","unstructured":"Roche K, Paul N, Smuck B, Whitehead M, Zee B, Pater J, et al. Factors affecting workload of cancer clinical trials: results of a multicenter study of the national Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2002;20(2):545\u201356.","journal-title":"J Clin Oncol"},{"issue":"5","key":"461_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1177\/17407745231177885","volume":"20","author":"SA Freel","year":"2023","unstructured":"Freel SA, Snyder DC, Bastarache K, Jones CT, Marchant MB, Rowley LA, et al. Now is the time to fix the clinical research workforce crisis. Clin Trials. 2023;20(5):457\u201362.","journal-title":"Clin Trials"},{"key":"461_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.33393\/ao.2023.2508","volume":"10","author":"S Stabile","year":"2023","unstructured":"Stabile S, Cenna R, Sinna V, Veronica F, Mannozzi F, Federici I, et al. Clinical trial units and clinical research coordinators: a system facing crisis? AboutOpen. 2023;10:1\u20133.","journal-title":"AboutOpen."},{"issue":"1","key":"461_CR23","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s13063-022-06315-8","volume":"23","author":"EJ Mitchell","year":"2022","unstructured":"Mitchell EJ, Goodman K, Wakefield N, Cochran C, Cockayne S, Connolly S, et al. Clinical trial management: a profession in crisis? Trials. 2022;23(1):357.","journal-title":"Trials"},{"key":"461_CR24","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.oraloncology.2016.01.004","volume":"54","author":"LR Wall","year":"2016","unstructured":"Wall LR, Cartmill B, Ward EC, Hill AJ, Isenring E, Byrnes J, et al. \u201cScreenIT\u201d: computerized screening of swallowing, nutrition and distress in head and neck cancer patients during (chemo)radiotherapy. Oral Oncol. 2016;54:47\u201353.","journal-title":"Oral Oncol"},{"key":"461_CR25","unstructured":"Brown B. ScreenIT cancer\u2014online screening, Integrated care. Brisbane: Metro South Hospital and Health Service; 2019."},{"key":"461_CR26","unstructured":"Qualtrics [Internet]. Provo, Utah, USA; 2023 [cited 2024 Mar 12]. https:\/\/www.qualtrics.com."},{"key":"461_CR27","unstructured":"National Cancer Institute. NCI-PRO-CTCAE Items-English Item Library. Version 1.0 [Internet]. 2020 [cited 2022 Jan 16]. https:\/\/healthcaredelivery.cancer.gov\/pro-ctcae\/pro-ctcae_english.pdf."},{"key":"461_CR28","unstructured":"IBM Corp. IBM SPSS statistics for Macintosh. 2022."},{"key":"461_CR29","unstructured":"R Core Team. R: A language and environment for statistical computing [Internet]. Vienna: R Foundation for Statistical Computing; 2023. https:\/\/www.R-project.org\/."},{"key":"461_CR30","unstructured":"Posit team. RStudio: Integrated development environment for R [Internet]. Boston: Posit Software, PBC; 2023. http:\/\/www.posit.co\/"},{"key":"461_CR31","doi-asserted-by":"crossref","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics [Internet]. 1977;33(1):159\u201374. https:\/\/www.jstor.org\/stable\/2529310?origin=crossref","DOI":"10.2307\/2529310"},{"issue":"1","key":"461_CR32","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12874-019-0887-5","volume":"20","author":"C Honda","year":"2020","unstructured":"Honda C, Ohyama T. Homogeneity score test of AC1 statistics and estimation of common AC1 in multiple or stratified inter-rater agreement studies. BMC Med Res Methodol [Internet]. 2020;20(1):20. https:\/\/doi.org\/10.1186\/s12874-019-0887-5.","journal-title":"BMC Med Res Methodol [Internet]."},{"key":"461_CR33","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jss.2022.09.020","volume":"282","author":"AJ Reiter","year":"2023","unstructured":"Reiter AJ, Sullivan GA, Hu A, Tian Y, Ingram MCE, Balbale SN, et al. Pediatric patient and caregiver agreement on perioperative expectations and self-reported outcomes. J Surg Res [Internet]. 2023;282:47\u201352.","journal-title":"J Surg Res [Internet]."},{"key":"461_CR34","unstructured":"Gwet K. irrCAC: computing chance-corrected agreement coefficients (CAC) [Internet]. 2019. https:\/\/CRAN.R-project.org\/package=irrCAC."},{"issue":"4","key":"461_CR35","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.clinthera.2016.03.011","volume":"38","author":"E Basch","year":"2016","unstructured":"Basch E, Rogak LJ, Dueck AC. Methods for implementing and reporting patient-reported outcome (PRO) measures of symptomatic adverse events in cancer clinical trials. Clin Ther [Internet]. 2016;38(4):821\u201330.","journal-title":"Clin Ther [Internet]."},{"key":"461_CR36","unstructured":"Grahvendy M, Brown B, Wishart LR. Cancer clinical trial patients\u2019 perceptions of reporting adverse events via an electronic platform. [Manuscript submitted for publication]. 2024."},{"issue":"10","key":"461_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11912-016-0549-2","volume":"18","author":"JP Botero","year":"2016","unstructured":"Botero JP, Thanarajasingam G, Warsame R. Capturing and incorporating patient-reported outcomes into clinical trials: practical considerations for clinicians. Curr Oncol Rep [Internet]. 2016;18(10):1\u20136. https:\/\/doi.org\/10.1007\/s11912-016-0549-2.","journal-title":"Curr Oncol Rep [Internet]."},{"issue":"36","key":"461_CR38","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1200\/EDBK_159514","volume":"36","author":"PG Kluetz","year":"2016","unstructured":"Kluetz PG, Chingos DT, Basch E, Mitchell SA. Patient-reported outcomes in cancer clinical trials: measuring symptomatic adverse events with the National Cancer Institute\u2019s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Am Soc Clin Oncol Educ Book [Internet]. 2016;36(36):67\u201373. https:\/\/doi.org\/10.1200\/EDBK_159514.","journal-title":"Am Soc Clin Oncol Educ Book [Internet]."},{"issue":"4","key":"461_CR39","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ijrobp.2021.11.024","volume":"112","author":"JR Wilkie","year":"2022","unstructured":"Wilkie JR, Hochstedler KA, Schipper MJ, Matuszak MM, Paximadis P, Dominello MM, et al. Association between physician- and patient-reported symptoms in patients treated with definitive radiation therapy for locally advanced lung cancer in a statewide consortium. Int J Radiat Oncol Biol Phys [Internet]. 2022;112(4):942\u201350.","journal-title":"Int J Radiat Oncol Biol Phys [Internet]."},{"key":"461_CR40","doi-asserted-by":"crossref","unstructured":"Veitch ZW, Shepshelovich D, Gallagher C, Wang L, Abdul Razak AR, Spreafico A, et al. Underreporting of symptomatic adverse events in phase i clinical trials. JNCI J Natl Cancer Inst [Internet]. 2021;113(8):980\u20138. https:\/\/academic.oup.com\/jnci\/article\/113\/8\/980\/6146406.","DOI":"10.1093\/jnci\/djab015"},{"issue":"1","key":"461_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s11136-017-1700-8","volume":"27","author":"A Tom","year":"2018","unstructured":"Tom A, Bennett AV, Rothenstein D, Law E, Goodman KA. Prevalence of patient-reported gastrointestinal symptoms and agreement with clinician toxicity assessments in radiation therapy for anal cancer. Qual Life Res [Internet]. 2018;27(1):97\u2013103. https:\/\/doi.org\/10.1007\/s11136-017-1700-8.","journal-title":"Qual Life Res [Internet]."},{"issue":"13","key":"461_CR42","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1002\/cncr.32898","volume":"126","author":"KA Nyrop","year":"2020","unstructured":"Nyrop KA, Deal AM, Reeve BB, Basch E, Chen YT, Park JH, et al. Congruence of patient- and clinician-reported toxicity in women receiving chemotherapy for early breast cancer. Cancer [Internet]. 2020;126(13):3084\u201393.","journal-title":"Cancer [Internet]."},{"key":"461_CR43","doi-asserted-by":"crossref","unstructured":"Atkinson TM, Dueck AC, Satele D V., Thanarajasingam G, Lafky JM, Sloan JA, et al. Clinician vs patient reporting of baseline and postbaseline symptoms for adverse event assessment in cancer clinical trials. JAMA Oncol [Internet]. 2020;6(3):437\u20139. https:\/\/jamanetwork.com\/journals\/jamaoncology\/fullarticle\/2757517.","DOI":"10.1001\/jamaoncol.2019.5566"},{"key":"461_CR44","doi-asserted-by":"crossref","unstructured":"Basch E, Iasonos A, McDonough T, Barz A, Culkin A, Kris MG, et al. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol [Internet]. 2006;7(11):903\u20139. http:\/\/oncology.thelancet.comVol.","DOI":"10.1016\/S1470-2045(06)70910-X"},{"key":"461_CR45","doi-asserted-by":"crossref","unstructured":"Kim J, Singh H, Ayalew K, Borror K, Campbell M, Johnson LL, et al. Use of PRO measures to inform tolerability in oncology trials: implications for clinical review, IND safety reporting, and clinical site inspections. Clin Cancer Res [Internet]. 2018;24(8):1780\u20134. https:\/\/clincancerres.aacrjournals.org\/content\/24\/8\/1780.","DOI":"10.1158\/1078-0432.CCR-17-2555"},{"issue":"8","key":"461_CR46","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1007\/s00520-016-3297-9","volume":"24","author":"TM Atkinson","year":"2016","unstructured":"Atkinson TM, Ryan SJ, Bennett AV, Stover AM, Saracino RM, Rogak LJ, et al. The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): a systematic review. Support Care Cancer [Internet]. 2016;24(8):3669\u201376.","journal-title":"Support Care Cancer [Internet]."},{"key":"461_CR47","doi-asserted-by":"crossref","unstructured":"Bruner DW, Hanisch LJ, Reeve BB, Trotti AM, Schrag D, Sit L, et al. Stakeholder perspectives on implementing the National Cancer Institute\u2019s patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Transl Behav Med [Internet]. 2011;1(1):110\u201322. https:\/\/academic.oup.com\/tbm\/article\/1\/1\/110\/4563030.","DOI":"10.1007\/s13142-011-0025-3"}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-024-00461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-024-00461-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-024-00461-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T08:09:08Z","timestamp":1732608548000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-024-00461-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,2]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["461"],"URL":"https:\/\/doi.org\/10.1007\/s40801-024-00461-y","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"type":"print","value":"2199-1154"},{"type":"electronic","value":"2198-9788"}],"subject":[],"published":{"date-parts":[[2024,11,2]]},"assertion":[{"value":"3 October 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors disclose receipt of the following financial support for the research, authorship, and\/or publication of this article: This work was supported by the Metro South Health SERTA Committee [grant number 252-19\/20]; Metro South Health SERTA Research Support Scheme, Novice Researcher [grant number RSS_2021_027].","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The datasets generated during and\/or analysed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Queensland Health Metro South Hospital and Health Service Human Research Ethics Committee (29 April 2021 \/ No. HREC\/2021\/QMS\/73409).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"M.G. conceptualised the study, recruited and consented participants, collected and analysed data and wrote the manuscript. B.B. and L.W. developed the concept for the study, analysed the data and contributed to writing the manuscript. All authors read and approved the final manuscript.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}